We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
51
Biogen
BIIB
$29.9B
$42.8M 0.81%
129,473
+123,342
+2,012% +$40.7M
NGLS
52
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$42.3M 0.8%
584,914
+167,174
+40% +$11.7M
ECL icon
53
Ecolab
ECL
$75.6B
$42.1M 0.79%
366,949
-11,711
-3% -$1.32M
ICLR icon
54
Icon
ICLR
$12.8B
$41.9M 0.79%
732,554
-18,080
-2% -$931K
QCOM icon
55
Qualcomm
QCOM
$176B
$40.5M 0.76%
541,880
+1,173
+0.2% +$89.7K
WYNN icon
56
Wynn Resorts
WYNN
$10.1B
$38.9M 0.73%
207,788
-999
-0.5% -$197K
ACN icon
57
Accenture
ACN
$89.9B
$35.7M 0.67%
438,694
-173,882
-28% -$13.9M
BN icon
58
Brookfield
BN
$102B
$35.2M 0.66%
3,340,493
+35,956
+1% +$387K
BIDU icon
59
Baidu
BIDU
$35.8B
$34.9M 0.66%
159,743
+129,618
+430% +$27.4M
TROW icon
60
T. Rowe Price
TROW
$25B
$34.7M 0.65%
442,761
-295,389
-40% -$23.7M
AGN
61
DELISTED
Allergan Inc
AGN
$34.7M 0.65%
194,698
-44,669
-19% -$7.42M
CRM icon
62
Salesforce
CRM
$134B
$34.2M 0.64%
593,639
-41,709
-7% -$2.35M
WHR icon
63
Whirlpool
WHR
$2.42B
$34.1M 0.64%
233,788
+2,417
+1% +$357K
HAL icon
64
Halliburton
HAL
$27.9B
$32.1M 0.6%
497,072
+139,126
+39% +$9.54M
URI icon
65
United Rentals
URI
$71.1B
$31.6M 0.6%
284,775
-20,926
-7% -$2.35M
ROK icon
66
Rockwell Automation
ROK
$51.4B
$29.8M 0.56%
271,124
+1,379
+0.5% +$162K
SCU
67
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$28.8M 0.54%
269,118
+541
+0.2% +$69.1K
CHRD icon
68
Chord Energy
CHRD
$7.79B
$28.3M 0.53%
676,601
-82,386
-11% -$4.1M
DISCK
69
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$27.5M 0.52%
+736,897
New +$29.8M
CPA icon
70
Copa Holdings
CPA
$5.56B
$26.6M 0.5%
248,200
-191,373
-44% -$25.5M
SUN icon
71
Sunoco
SUN
$14.2B
$26.1M 0.49%
475,308
+365,553
+333% +$19.3M
EQM
72
DELISTED
EQM Midstream Partners, LP
EQM
$26M 0.49%
290,097
+1,847
+0.6% +$170K
CP icon
73
Canadian Pacific Kansas City
CP
$82B
$25.2M 0.47%
607,115
-69,105
-10% -$2.71M
RHI icon
74
Robert Half
RHI
$3.61B
$24.8M 0.47%
505,354
+429,588
+567% +$21.3M
CNC icon
75
Centene
CNC
$31.3B
$23.5M 0.44%
1,136,396
+440,284
+63% +$8.49M

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.